News Alert:

Case Studies

At Health Enterprise East we believe in improving healthcare through technology and innovation

Book you free consultation today

Waiting List Simulation of a Teledermoscopy Tool for Skin Cancer Screening​ – Open Medical

Waiting List Simulation of a Teledermoscopy Tool for Skin Cancer Screening​ – Open Medical

The Challenge The team at Open Medical have developed a novel teledermoscopy tool aimed to enhance the triage of dermatology referrals, particularly for suspected skin cancer. This tool holds the promise to considerably shorten the journey from referral to the final diagnosis, optimising the utilisation of healthcare resources. The innovators asked HTE to use its expertise to […]

Cost-Utility Analysis for IBS Intervention: NHS Drug Tariff Application

Cost-Utility Analysis for IBS Intervention: NHS Drug Tariff Application

The client had a novel product for use in patients with irritable bowel syndrome (IBS) and wished to have its product listed on the NHS Drug Tariff. To support the application, a health economic evaluation was required to demonstrate the relative cost-effectiveness of the intervention.

Economic Analysis of a Novel Graft Material for Ophthalmology – The Electrospinning Company

Economic Analysis of a Novel Graft Material for Ophthalmology – The Electrospinning Company

The team at the Electrospinning Company have developed a novel synthetic material intended for use as a graft in ophthalmic surgery. The innovative material has the potential to improve surgical outcomes in addition to being more economical that the currently used graft options.

Budget Impact Analysis of a SMART Referral System – DXS

Budget Impact Analysis of a SMART Referral System – DXS

An innovator has developed a smart referral solution. The innovation is expected to enhance efficiencies in primary and secondary care by reducing inappropriate referrals, excessive secondary care appointments, repeat GP consultations, and the administrative burden associated with triaging and managing incorrect referrals.

Budget Impact Analysis of a Digital Dietary Education Programme​ – Freshwell

Budget Impact Analysis of a Digital Dietary Education Programme​ – Freshwell

The innovators had developed a digital dietary education program, targeting adults with a BMI greater than 25. The program is accessible through a website and also on a mobile app, it offers structured meal plans to the user.

Robotic Device for Colonoscopy Procedures – Aker Health Tech

Robotic Device for Colonoscopy Procedures – Aker Health Tech

The innovators at Aker Health Tech have developed an automated, self-propelled robotic colonoscopy device, capable of performing a complete colonoscopy for the lower gastrointestinal tract. This innovation is projected to significantly reduce the duration of the colonoscopy procedure and the required staffing resources.

Cost Saving Analysis of a Tumour Profiling Test – Digistain

Cost Saving Analysis of a Tumour Profiling Test – Digistain

Our client has developed an innovative tumour-grading technology that has the potential to revolutionize breast cancer treatment. This technology enables the stratification of patients based on their risk of cancer recurrence, aiming to reduce the amount of unnecessary chemotherapy treatments that are delivered.

Evaluation of a secure and real-time communication solution in an NHS hospital – Medic Bleep

Evaluation of a secure and real-time communication solution in an NHS hospital – Medic Bleep

Communications between clinical and operational staff at West Suffolk Hospital (WSH) relied on the use of pagers, which has proved to be inefficient and suboptimal.​ Health Innovation East engaged Health Tech Enterprise (HTE) to independently evaluate the implementation and benefits of Medic Bleep, a communication tool developed to improve service efficiency and reduce delays in sharing information between clinical and operational staff.

Rapid Point of Care  Diagnostic Test – University of South Wales

Rapid Point of Care Diagnostic Test – University of South Wales

The University of South Wales (USW) sought to commercialise a novel point of care device, developed by USW researchers, for rapidly testing COVID-19. The Brief The University was working with Public Health Wales, the University Health Board and local industry to collaboratively develop the device to meet regulatory, clinical and commercial requirements. The University required […]

Clinical Innovators Forum

Clinical Innovators Forum

The Clinical Innovators Forum is designed to provide innovators with access to specialist support and advice to help take their technology innovation projects from concept through to commercialisation.

Introducing an innovative pain management infusion pump to the UK and EU markets – Daiken Medical

Introducing an innovative pain management infusion pump to the UK and EU markets – Daiken Medical

Daiken Medical, a Japanese Medical Device Manufacturer, were seeking regulatory approval to launch one of their innovative patient-controlled analgesia (PCA) infusion pumps in Europe, with a particular focus on the UK market.

A liquid biopsy test which screens and predicts cardiovascular disease – MultiplAI

A liquid biopsy test which screens and predicts cardiovascular disease – MultiplAI

MultiplAI are developing an RNA based, liquid biopsy which screens for and predicts cardiovascular disease by assessing the presence of atherosclerotic plaques in the blood. The innovation is being developed as a service for use in screening for coronary heart disease.

Modelling the Carbon Footprint of a Novel Digital Innovation – Neuhealth

Modelling the Carbon Footprint of a Novel Digital Innovation – Neuhealth

Neu Health developed a digital platform for people with Parkinson’s and dementia. The innovation facilitates patient empowerment and enables clinicians to close the care management and data gap between clinic visits, as well as reduce unnecessary journeys for both patients and healthcare professionals.

Carbon Footprint Savings Enabled by Tumour Profiling Test – Digistain

Carbon Footprint Savings Enabled by Tumour Profiling Test – Digistain

Our client developed an innovative tumour-grading technology that enables the stratification of patients based on their risk of cancer recurrence, guiding the use of chemotherapy. The client sought to understand the quantitative evidence on the reduction of carbon footprint resulting from decreased patient travel and improved logistics.

Delivering Clinical Entrepreneurship Training – UCL Partners

Delivering Clinical Entrepreneurship Training – UCL Partners

UCL Partners is a leading Academic Health Science Network that focuses on driving research and innovation to improve patient care and promote better health outcomes. In 2022, they launched the first UCL Partners Innovation Fellowship Programme, which supports NHS fellows in developing digital-based health solutions.

Cost Effectiveness Analysis on AI Tool to Support Diagnosis of Prostate Cancer – Lucida Medical

Cost Effectiveness Analysis on AI Tool to Support Diagnosis of Prostate Cancer – Lucida Medical

Lucida Medical develops software based on artificial intelligence methods (machine learning and image processing) to enable radiologists to find cancer accurately, consistently, and quickly using MRI. Innovators at Lucida Medical developed Prostate Intelligence (PI™) to support the diagnosis of prostate cancer in patients.

CamPROBE Prostate Biopsy Device – Cambridge University Hospitals NHS Foundation Trust

CamPROBE Prostate Biopsy Device – Cambridge University Hospitals NHS Foundation Trust

Professor Vincent Gnanapragasam and colleagues developed the Cambridge Prostate Biopsy Device (CamPROBE®), an innovative device to safely access the prostate using fewer incisions through the perineum instead of via the transrectal route. As such, the device reduces the risk of infection.

Developing an Early Value Assessment Tool – InnoScot Health

Developing an Early Value Assessment Tool – InnoScot Health

InnoScot Health work in close partnership with NHS Scotland to support the development of innovative ideas to improve patient care. They identified the need for a value assessment tool to enable their team to evaluate early-stage innovations, identify viable opportunities and efficiently allocate resources to deliver value and improvement to the NHS.

Medtech Navigator Programme

Medtech Navigator Programme

The MedTech Navigator programme identified clinical or organisational areas of unmet needs in healthcare and provided a platform for medical technology SMEs to respond to those needs by developing innovative new products and services.

Decision Support Tool for Alzheimer’s Disease – University of Cambridge

Decision Support Tool for Alzheimer’s Disease – University of Cambridge

Innovators from the Department of Clinical Neurosciences at the University of Cambridge had developed a machine learning algorithm to predict the speed of progression of Alzheimer’s disease. This decision support tool would enable physicians to better manage their patients by assigning them to the most appropriate treatment pathway.

Non-invasive Molecular Test for those with Suspected Prostrate Cancer – Cambridge Oncometrix

Non-invasive Molecular Test for those with Suspected Prostrate Cancer – Cambridge Oncometrix

ONX is a non-invasive molecular test developed by UK based Cambridge Oncometrix. The test will enable risk-stratification and improve true positive rates within the diagnostic pathway for those with suspected prostate cancer. ONX will be conducted prior to multi-parametric magnetic resonance imaging scanning, a relatively new prostate cancer screening method. As a result, ONX will alleviate the burden placed on access to mpMRI scans.

ENDOVAC™: Pioneering Endoscopic Surgical Device  – Cambridge University Hospitals NHS Trust

ENDOVAC™: Pioneering Endoscopic Surgical Device – Cambridge University Hospitals NHS Trust

Each year, around 2,800 people in the UK experience a hole in their upper gastrointestinal (GI) tract. The presence of a hole allows leakage of gastrointestinal contents into the body which quickly leads to infection – a serious medical emergency that can be fatal if not treated. ENDOVAC™ is a pioneering endoscopic surgical device to solve this problem.

Ablatus Therapeutics – Norfolk and Norwich University Hospitals NHS FT

Ablatus Therapeutics – Norfolk and Norwich University Hospitals NHS FT

Radiofrequency Ablation (RFA) is an established technique for the treatment of soft tissue with applications in oncology, women’s health and cardiology. RFA uses Alternating Current to generate radiofrequency (RF) energy, which when delivered to target tissues via a probe, results in localised heating and tissue destruction.

Arterial Non-Injectable Connector (NIC) – Queen Elizabeth Hospital King’s Lynn NHS FT

Arterial Non-Injectable Connector (NIC) – Queen Elizabeth Hospital King’s Lynn NHS FT

Arterial lines are frequently used in intensive care units and operating theatres to facilitate beat-to-beat monitoring of blood pressure and to allow blood sampling. The Needle-Free Arterial Non-injectable Connector (NIC) is a novel device which increases the safety of patients undergoing blood sampling.

Self Management App for Improved Dental Health – Brush DJ

Self Management App for Improved Dental Health – Brush DJ

The Brief Brush DJ was developing a state-of-the-art self-management dental app to improve oral health and make brushing your teeth fun! Brush DJ is an award-winning, free toothbrush timer app that plays 2 minutes of music taken from the user’s device to encourage brushing for an effective length of time. The app also allows users […]

Earfold™: An Innovative Treatment for Prominent Ears – West Hertfordshire Hospitals NHS FT

Earfold™: An Innovative Treatment for Prominent Ears – West Hertfordshire Hospitals NHS FT

A new approach to treating prominent ears, which affects 5-10% of the UK population, was developed by Dr Norbert Kang using an implant manufactured from a high technology memory metal which can be inserted subcutaneously under the skin of the ear. This quick and effective procedure performed under local anaesthetic has fewer side effects than conventional otoplasty surgery and is less invasive.

Validating the Clinical Need for Innovative Obstetric Devices

Validating the Clinical Need for Innovative Obstetric Devices

The Brief An innovation development company approached us to validate the clinical need for two innovative obstetric devices and gain additional insight from clinicians and feedback on the current market readiness for these devices. Our intervention We undertook face to face interviews with clinicians using a pre-agreed interview guide to steer the discussion and focused […]

Priority.You: Digital Screening and Demand-Management Tool – Priority Digital Health

Priority.You: Digital Screening and Demand-Management Tool – Priority Digital Health

Priority Digital Health aims to streamline and connect primary care health and wellbeing services using digital technologies to facilitate social prescribing. The company created a new digital screening and demand-management tool, priority.you which enables GP practices to triage patients into – or out of – practices safely and effectively according to need.

TracheSeal: Sterile Wound Dressing – Cambridge University Hospitals NHS FT

TracheSeal: Sterile Wound Dressing – Cambridge University Hospitals NHS FT

It is conservatively estimated that 4M temporary tracheostomies are performed throughout Europe and the US each year. The procedure involves making an incision on the anterior aspect of the neck, and opening a direct airway through an incision in the trachea. Tracheseal is a dedicated tracheostomy wound dressing to be used after the removal of the tracheostomy tube.

SAFIRA®: Safer Injection for Regional Anaesthesia – Queen Elizabeth Hospital King’s Lynn NHS FT

SAFIRA®: Safer Injection for Regional Anaesthesia – Queen Elizabeth Hospital King’s Lynn NHS FT

Regional anaesthesia is directed at a specific region of the body to allow a surgical operation or provide post-operative pain relief. SAFIRA makes regional anaesthesia a one person procedure, putting control in the hands of the anaesthesiologist.

Stay in Touch:

Keep up to date with all HTE news and events.

Subscribe to our mailing list